Ashfield Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Ashfield Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $180,530 - $235,578	-2,982 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$71.28 - $78.92 $212,556 - $235,339	2,982 New	2,982 $230,000
Q2 2018 Jul 26, 2018	SELL	$64.88 - $75.68 $182,961 - $213,417	-2,820 Closed	0 $0
Q3 2017 Nov 07, 2017	SELL	$72.11 - $85.47 $51,558 - $61,111	-715 Reduced 20.23%	2,820 $228,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,535	3,535 $250,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ashfield Capital Partners, LLC with notifications on news.